ベータ
治験レーダーAI
治験 NCT05412862 (PEACE-V)(対象:急性冠症候群、身体不活動)は募集中です。詳細は治験レーダーのタイル表示と AI 発見ツールで確認するか、ここで質問してください。
フィルター基準に一致する試験が1件見つかりました
タイル表示

Positive Emotions Following Acute Cardiac Events (PEACE-V)

募集中
治験(臨床試験)の詳細は主に英語で提供されています。しかし、治験レーダーAIが支援できます!「治験を説明」をクリックして、選択した言語で試験情報を表示し、議論してください。
治験番号 NCT05412862 (PEACE-V) は 介入研究 臨床試験 で、急性冠症候群、身体不活動 に関するものです。現在は 募集中 で、2022年9月12日 から開始しています。280 名の参加者 の募集が計画されています。この治験は Massachusetts General Hospital によって主催され、2027年6月30日 に完了予定です。ClinicalTrials.gov からの最新更新日は 2024年4月17日 です。
概要
The focus of this study is to test the efficacy of a 12-week, remotely delivered, positive-psychology-motivational interviewing (PP-MI) intervention, with additional twice weekly text messages for a total of 24 weeks (with interactive, algorithm-driven, goal-focused text messages in the final 12 weeks), compared to post-acute coronary syndrome (ACS) treatment as usual, in a randomized trial of 280 post-ACS patients with low baseline physical activity.
詳細説明
The investigators are proposing a study that will focus on testing the efficacy of a PP-MI intervention, with additional twice text messages for a total of 24 weeks (with interactive, algorithm-driven, goal-focused text messages in the final 12 weeks) in post-ACS patients. The investigators will enroll 280 post-ACS patients, who will take part in either a 12-week intervention (with 24 weeks of supplemental text messages), or receive post-ACS treatment as usual.

In this project, the investigators hope to do the following:

  1. Examine the efficacy of a 12-week, phone-delivered PP-MI intervention for individuals with ACS on physical activity-related outcomes, as compared to the treatment as usual group.
  2. Assess the intervention's impact on psychological (e.g. positive affect), functional (e.g. physical function), and behavioral (e.g. overall adherence) outcomes.
  3. Explore the intervention's impact on markers of cardiovascular health (e.g., cardiac biomarkers), as well as major adverse cardiac events/readmissions.

Participants will be screened and enrolled during admission for an ACS. They will be provided with a accelerometer to monitor their physical activity for one week prior to their first in-person visit. At their first visit, they will answer questionnaires related to psychological and physical health and functioning, have their blood pressure and weight measured, and provide a fasting blood sample. Upon confirmation of adequate physical activity, participants will be randomized to receive the PP-MI intervention or treatment as usual.

Participants in the intervention will be provided a treatment manual, an activity tracker, and other treatment materials. The intervention will be introduced, and the first exercise will be assigned.

Following the first in-person visit, participants in the treatment condition will complete twelve weekly phone sessions with a study trainer. The phone sessions primarily will include a review of the prior week's session content and a discussion of the rationale and assignment of the next week's exercise/assignment.

Participants in the treatment condition will receive twice weekly text messages throughout the intervention (Weeks 1-12) and initial follow-up period (Weeks 13-24). These messages will focus on the PP activity and physical activity. During Weeks 13-24, participants in the PP-MI condition will engage with twice weekly, automated, interactive text messages related to PP and physical activity.

At Weeks 12, 24, and 48, participants will complete follow-up visits. One week prior to these visits, participants will be mailed an accelerometer and will wear it until their study visit. During these study visits, participants will be asked to answer questionnaires related to psychological and physical health and functioning, have their blood pressure and weight measured, and be asked about cardiovascular outcomes, including hospitalizations, cardiovascular procedures, and cardiac-specific hospitalizations. They will also provide a fasting blood sample.

Finally, participants will complete phone sessions every 6 months until study end to inquire about hospitalizations and adverse cardiac events.

公式タイトル

A Novel Psychological-behavioral Intervention to Promote Physical Activity After Acute Coronary Syndrome

疾患/病気
急性冠症候群身体不活動
その他の研究識別子
  • PEACE-V
  • 2021P003302
NCT番号
開始日
2022-09-12
最終更新日
2024-04-17
終了予定日
2027-06-30
目標参加者数
280
試験の種類
介入研究
治験の相・段階
該当なし
状況
募集中
キーワード
Positive psychology
Physical Activity
Motivational Interviewing
Adherence
主目的
治療
割付方法
無作為化
介入モデル
並行割当
盲検化
単盲検
群(アーム)/介入
参加グループ/群介入/治療法
実験的Positive Psychology + Motivational Interviewing
Each week, participants in the PP-MI intervention group will complete a PP activity and work towards a physical activity goal, then complete a phone session with a study trainer. Each phone session will include PP and goal setting portions. In the PP portion, the study trainer will (a) review the week's PP exercise, (b) discuss the rationale of the next week's PP exercise through a guided review of the PP-MI manual, and (c) assign the next week's PP exercise. In the goal-setting portion, the trainer will (a) review the participant's physical activity goal from the prior week, (b) discuss techniques for improving physical activity (e.g. tracking activity), and (c) help the participant to set a physical activity goal for the next week. Participants also will receive supplemental text messages throughout the 12 weeks of the intervention and during the initial follow-up period (Week 13-24).
Positive Psychology + Motivational Interviewing
The 12-week PP-MI intervention focuses on enhancing well-being (through PP) and increasing physical activity (through MI). Each week, participants will complete a PP activity and work towards a physical activity goal, then complete a phone session with a study trainer. The PP portion of the program will focus on the cultivation of well-being through the performance of easy-to complete activities (e.g., using a strength in a new way) and review of the positive feelings they generate. The MI portion of the program will focus on assisting participants to improve physical activity levels, resolve ambivalence to behavior change, set realistic physical activity goals, problem-solve barriers, and identify resources to complete behavior change. Finally, participants will receive twice weekly text messages (for 24 weeks) to encourage completion of PP activities and engagement in physical activity.
非介入Treatment as Usual
Participants in the treatment as usual (TAU) arm will not receive any specific intervention, though they will be free to receive any post-ACS treatment.
該当なし
主要評価項目
評価指標指標の説明時間枠
Change from Baseline Moderate to Vigorous Physical Activity (MVPA) at 24 weeks
MVPA will be measured via an accelerometer and recorded in mean minutes/day.
Measured for 7 days at baseline and 24 weeks
副次評価項目
評価指標指標の説明時間枠
Change in Light Intensity Activity
Light intensity activity will be measured via an accelerometer and recorded in mean minutes/day.
Measured for 7 days at baseline, 12 weeks, 24 weeks, and 48 weeks
Change in positive affect (Positive and Negative Affect Schedule [PANAS] positive affect items)
The positive affect items on the Positive and Negative Affect Schedule (PANAS), a well-validated scale used in other intervention trials and in patients with HF, will be used to measure positive affect (Range: 10-50). Higher scores indicate higher levels of positive affect.
Baseline, 12 weeks, 24 weeks, 48 weeks
適格基準

対象年齢
成人, 高齢者
試験の最低年齢
18 Years
対象性別
全て
  • ACS (myocardial infarction or unstable angina)
  • Suboptimal physical activity (score of < 6 on the Medical Outcomes study Specific Adherence Scale item related to physical activity)

  • Cognitive deficits (assessed via a 6-item cognitive screening tool)
  • Medical conditions likely to lead to death within 6 months.
  • Moderate-severe depression (Patient Health Questionnaire-9 [PHQ-9] score ≥15)
  • Inability to participate in physical activity due to another medical condition (e.g., arthritis)
  • Inability to read, write, or speak in English
  • Inability to receive text-messages
  • Current participation in another intervention or program that has been designed to promote well-being or physical activity
Massachusetts General Hospital logoMassachusetts General Hospital
責任者
Jeff C. Huffman, MD, 研究責任者, Director, Cardiac Psychiatry Research Program, Massachusetts General Hospital
試験中央連絡先
連絡先: Jeff C Huffman, M.D., 617-724-2910, [email protected]
1 1カ国の場所

Massachusetts

Massachusetts General Hospital, Boston, Massachusetts, 02114, United States
Jeff Huffman, M.D., 連絡先, 617-724-2910, [email protected]
募集中